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Executive Summary 
7.  The executive summary must not exceed 2 sides in total of A4 and should be understandable to the 
intelligent non-scientist.  It should cover the main objectives, methods and findings of the research, together 
with any other significant events and options for new work.
 
Mastitis is the most significant disease affecting the health, welfare and economic productivity of dairy cattle and is 
recognised by Defra as a major economic and welfare concern. Research into the efficacy of homeopathic treatments 
and of management control of mastitis on organic dairy farms have both been identified as research priorities in 
recent Defra funded reviews of organic dairy farming.  This study examined the use of a specific mode of 
homeopathic treatment in the prevention of mastitis and quantified the effect that the year-round, prophylactic use of 
nosodes, supplied to the cattle in the drinking water, had on the number of clinical cases of mastitis on somatic cell 
counts within herds. 
 
Context and background 
Organic dairy farming is a significant industry with milk being the largest single organic product in the UK.  Organic 
milk is produced to defined standards which meet the Advisory Committee on Organic Standards (ACOS) criteria. 
These standards ‘emphasise animal welfare and, by avoiding artificial fertilisers, pesticides and other non-natural 
chemicals, and prohibiting the routine use of antibiotics and other conventional drugs, also ensure care for the 
environment, and promote the highest standards of food quality and safety’ (Omsco 2005).  As part of the 
management of organic dairy cattle with reduced use of conventional pharmaceutical treatments, many organic 
farmers use homeopathic and other complementary therapies on their animals.  
 
Mastitis is recognised as the main animal health problem in organic milk production systems (Bennedsgaard et al 
2003). Whilst mastitis levels appear to be similar to those found in conventional production (Hovi and Roderick, 2000) 
specific problem areas in mastitis control under organic management standards have been identified.  
One of the overall goals of organic animal husbandry is to avoid disease through management, husbandry, breeding 
and feeding. According to the EC-Regulation No. 1804/1999 governing organic livestock production, animal health 
management should be based on disease prevention. However, the preventive use of chemically synthesised 
allopathic medicinal products like dry cow antibiotics is not permitted. In organic units, phytotherapeutic and 
homeopathic products and trace elements are to be used in preference to antibiotic and prolonged withdrawal periods 
need to be observed after conventional medicine use. As a consequence of these requirements, organic dairy farmers 
look for alternatives to conventional therapy and prophylaxis (Hektoen 2004). 
Homeopathy is widely used for the treatment of mastitis within UK organic dairy herds and prophylactic use of SID 5 (2/05)  Page 4 of 29 
homeopathic nosodes, either continuously or just during housing, is practised on many organic dairy farms and is 
thought to offer general protection against mastitis and to reduce somatic cell counts (SCC). Research into the 
effectiveness of homeopathic treatments was one of the most important research requirements identified in a recent 
MAFF review of animal health within organic herds ( Hovi & Roderick 1999).  
 
The range of homeopathic treatments used on farm today is wide, with treatment practices either focussing on the 
needs of the individual animal, which is known as constitutional treatment and which employs individual remedies, or 
aimed at groups of animals using specific remedies, or ‘nosodes’, which are considered to be a very specific form of 
homeopathy - isopathy  (iso - all the same,  pathy – treatment/exposure). Unlike specific remedies, nosodes do not 
account for the individual needs of each animal, but create the potential for protective treatment for a herd or group, 
they are generally applied in drinking water, and may be used on individual animals, usually by vulval spray.  
 
 
Benefit for the sector and for Defra 
Mastitis is the most significant disease affecting the health, welfare and economic productivity of dairy cattle, and 
management and control of mastitis is an important facet of practical dairy herd management. Mastitis is recognised 
by Defra as a major economic and welfare problem in dairy cattle. Research into the efficacy of homeopathic 
treatments and of management control of mastitis on organic dairy farms have both been identified as research 
priorities in recent Defra funded reviews of organic dairy farming.  
 
The Study 
Ninety-six farms participated in a double-blind trial to compare a homeopathic nosode and an inactive control 
treatment (carrier alone). Treatments were at the farm level and took place over a period of 12 months or 24 months 
(some farms were swapped to the opposite treatment during a second year). The treatments were randomised to 
each farm by a third party. During the trial, where available, records were collected of farm monthly bulk tank somatic 
cell count (BMSSC), a monthly cell count based on National Milk Recording data (NMR) and the annual number of 
cases of mastitis as recorded by the farmer. Additional farm level data were collected and their relationship to the 
level of mastitis on the farms investigated. 
 
 
Objectives of the Study 
The study described in this report explores the use of a specific mode of homeopathic treatment, a nosode, in the 
prevention of mastitis and quantifies the effect that the year-round, prophylactic use of nosodes, supplied to the cattle 
in the drinking water, had in reducing the number of clinical cases of mastitis and also quantifying any effect that the 
use of a nosode has on somatic cell counts within herds. 
 
•  To quantify the effectiveness of the prophylactic use of homeopathic nosodes for the treatment of mastitis in 
reducing the incidence of clinical mastitis and the concentration of somatic cells in milk. 
•  To survey management practices on organically managed farms. 
•  To investigate associations between the homeopathic treatment, farm management practice and the 
incidence of different types of mastitis and to provide guidance for mastitis control in organic dairy herds. 
 
Materials and methods  
In testing the efficacy of a homeopathic nosode it was determined that the study should:  
 
•  Look at a nosode already being commonly used and commercially available. 
•  Not ask for new recording systems to be used for data collection but to use the existing systems which are in 
place. 
•  Not interfere in the ‘normal’ practises carried out by the farms, by, for example, repeated prompting of  
farmers to carry out treatments, or ask them to adopt prescribed ways for describing, recording or treating 
mastitis.  
 
There are three commonly used measures of the udder health of milking cows: 
 
a)  The bulk tank milk somatic cell count (BMSCC, commonly referred to as SCC) gives a count (in 000’s cells / 
ml) of white cells and desquamated cells shed by the udder. The BMSCC is not an accurate indicator for the 
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b)  Somatic cell counts for individual cows from farms which subscribe to commercial milk recording services 
(ICSCC). 
c)  The number of cases of mastitis.  The incidence rate for clinical mastitis (IRCM) is the number of distinct 
cases of mastitis in 100 cows in a year. 
 
The response variables that were measured were: 
 
•  Farmers’ own record of mastitis cases. 
•  Bulk milk SCC. 
•  Individual cow somatic cell records (ICSCC) if the farms were on a milk recording service.  
•  Farmer’s opinion of his/her success in controlling mastitis. 
•  A large number of variables, recorded using a questionnaire at the farm visits, which could influence mastitis 
and the effectiveness of the treatment.  
 
After visiting a number of homeopathic pharmacies, an agreement was made with Crossgates homeopathic 
pharmacy1, and  Freemans Homeopathic Pharmacy2 (Appendix D) to make the individual herd specific nosode 
remedies for the farms. The trial was double-blinded, with blinding carried out by the creation of a randomly generated 
list of A and B’s. As each new farm was recruited, it was allocated to the next A or B in the sequence, the farms being 
allocated to either nosode treatment or control, one by one, in chronological order. 
 
Articles were written in the organic press, Organic Farming, and The Turning Worm, inviting farms to take part in the 
study. It was clear that farms should only join the study voluntarily and would not be ‘cold called’ or pressurised to join. 
One hundred and four farms responded to the call, and 96 of these farms went on to take part in the study. The 8 
farms which declined to take part either went out of milk production before the study started, or changed their minds 
about inclusion in the trial before the start of the study. The 96 farms were visited and the study introduced. Farmers 
were issued with a kit to collect milk from high cell count cows for preparation as a nosode.  An 80 part questionnaire 
(Appendix A) was used to gather the information needed to understand the possible factors that may influence 
mastitis. During visits the farmers were also asked whether they were willing to fill in a self assessment of their 
personality type. 
 
Number of farms recruited      = 96 
Total farms completing the study period  = 88 
Number of farm years followed    = 206 
Average herd size      = 101 cows 
Number of cows followed in the study   = 9,680 
Number of cows receiving remedy  (R)   = 4,734 
Number of cows receiving control (P)  = 4,946 
Total cow years followed      =  21,580 cow years (Some farms two years, some 3 years) 
Farms lost during study      = 8  (due to sale of the herd, or going out of milk production  
and into, for example, heifer rearing) 
 
Results 
The data collected were subject to a number of different analyses:- 
1. A test for an effect of the homeopathic nosode in reducing the cell count in milk. 
2. A test for an effect of the homeopathic nosode in reducing the annual cases of mastitis. 
3. An analysis to identify risk factors associated with increased cell count in milk. 
4. An analysis to identify risk factors associated with higher levels of mastitis. 
 
No effect of nosode in reducing either the incidence of cases of mastitis or the somatic cell counts in the milk were 
detected. 
 
The following risk factors were found to be associated with composite cell counts:- 
•  A decrease in cell count with increased culling of high cell count cows 
•  A decrease in cell count for farms which use complementary therapies on dry cows 
•  A decrease in cell count for farms which use dry cow therapy, including teat sealants, on dry cows 
•  An increased  cell count for farms which did not pre-wipe before milking or pre-wiped the teats with a cloth 
before milking   
•  An increase in cell count for farms which pre-wipe only the udders of cows which are visibly dirty before 
milking  SID 5 (2/05)  Page 6 of 29 
 
The following risk factors were found to be associated with the number of cases of mastitis:- 
•  Increasing herd yield is associated with increased mastitis case numbers 
•  Increased calving of cows indoors in a calving box was associated with increased numbers of mastitis cases 
•  Use of an in line clot filer was associated with reduced numbers of mastitis cases 
•  Having an abreast parlour (as opposed to a herringbone or rotary parlour) was associated with a reduced 
numbers of mastitis cases 
 
The extent to which the objectives set have been achieved 
 
The effectiveness of homeopathic nosodes in treating mastitis and lowering cell count is quantified and described 
(Objective 1) and the survey results of management practices on organically managed dairy farms are described 
(Objective 2). Additionally, the associations between homeopathic treatment, farm management practices, mastitis 
incidence and cell count are quantified (Objective 4) and management controls which show a  reduction in mastitis 
cases or cell counts are identified as risk factors and described in the report (Objective 5). 
 
Conclusions 
•  There was no significant effect of the herd specific nosode on either the cell count of milk or the number of 
cases of mastitis. 
•  That there were strong ‘within farm’ correlations of cell count and cases i.e. between farms, farms tend to 
stay at the same level of cases and average cell count from year to year. 
•  That there was a characteristic pattern of seasonal change in cell counts (this is already widely recognised). 
•  The study provides useful and interesting statistics on organic dairy farm production. 
•  The study identified an association between decreased cell count and culling for high cell count, the use of 
complementary dry cow therapy and the use of traditional dry cow therapy. 
•  The study identified an association between increased cell count and not pre-wiping the udder, pre-wiping 
using a cloth and only pre-wiping dirty cows. 
•  The study identified an association between higher numbers of mastitis cases and higher average yield and 
also with higher percentage of cows calving in a calving box. 
•  An association was identified between decreased numbers of mastitis cases and the use of an in-line clot 
filter and also with farms with an abreast parlour (rather than a herring-bone parlour). 
•  Eighty five per cent of farmers in the survey responded that they did believe in non-conventional remedies, 
and 62 per cent of farmers responded that they used non-conventional remedies on their own family. 
 
 
 
Project Report to Defra 
8.  As a guide this report should be no longer than 20 sides of A4. This report is to provide Defra with 
details of the outputs of the research project for internal purposes; to meet the terms of the contract; and 
to allow Defra to publish details of the outputs to meet Environmental Information Regulation or 
Freedom of Information obligations. This short report to Defra does not preclude contractors from also 
seeking to publish a full, formal scientific report/paper in an appropriate scientific or other 
journal/publication. Indeed, Defra actively encourages such publications as part of the contract terms. 
The report to Defra should include: 
z  the scientific objectives as set out in the contract; 
z  the extent to which the objectives set out in the contract have been met; 
z  details of methods used and the results obtained, including statistical analysis (if appropriate); 
z  a discussion of the results and their reliability;  
z  the main implications of the findings;  
z  possible future work; and 
z  any action resulting from the research (e.g. IP, Knowledge Transfer). 
 
 
 
The Ojectives as set out in CSG7 
 
01 To quantify the effectiveness of the prophylactic use of homeopathic nosodes for the treatment of mastitis in reducing the 
incidence of clinical mastitis and the concentration of somatic cells in milk. 
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02 To survey management practices on organically managed farms. 
 
03* To provide information of the causal agents of mastitis found in organically managed herds for use in this project and for 
use by other workers in the field. 
  
04 Using the data from Objectives 02 and 03*, to investigate associations between the homeopathic treatment, farm 
management practice and the incidence of different types of mastitis. 
 
05 To provide a standard protocol on management and target setting for mastitis control in organic dairy herds based on the 
data obtained from the study.   
 
 
The Extent to which these objectives have been met 
 
Objectives 01 has been met and the results are described below. The effectiveness of homeopathic nosodes in treating 
mastitis and lowering cell count is quantified. 
 
Objective 02 has been met and the survey results of management practices on organically managed dairy farms are 
described below. 
 
The asterisked, optional Objective 03 in the proposal was not taken up by Defra. 
 
Objective 04 has been met and the results are described below. The associations between homeopathic treatment, farm 
management practices, mastitis incidence and cell count are quantified. 
 
Objective 05 A number of risk factors have been identified in this study. In liaison with Defra, guidance on management and 
target setting for organic dairy farmers, based on these risk factors, could be made available in a form for the internet and for 
distribution. The risk factors identified are very much in line with present recommendations for dairy farms in general ( see the 
Introduction, below, which outlines the ‘Five Point Plan’). 
 
Further Work 
In view of the current interest in sustainable farming issues particularly in the improvement of animal health and welfare in 
sustainable systems, development and improvement of sustainable livestock husbandry systems and improved environmental 
management of livestock systems, the risk factors identified in this study, in conjunction with other potential risk factors in 
organic dairy production, merit further study by means of controlled experimental trials. 
 
Actions resulting from the work 
With Defra’s permission we would wish to publish the findings of this study in the relevant scientific and industry journals. 
With Defra’s permission we would like to send an abstracted form of this report to the farmers who contributed to the study. 
 
 
Report - The use of homeopathic nosodes in the prevention of mastitis within organic dairy herds  DEFRA OF 0186 
 
 
INTRODUCTION 
 
The use of homeopathic remedies was first outlined by Hippocrates (400 BC) and developed into the forms recognised today 
by a German doctor Friedrich Samuel Hahnemann  (1755 – 1843). Hahnemann first experimented with cinchona bark 
(quinine) and found that ‘Like cures like’. Homeopathic treatments have been widely used in animals since Hahnemann, and, 
in dairy cattle, are used by many farmers as a part of their efforts to control mastitis, which, (alongside lameness and foot 
problems), is a very significant animal disease and welfare problem as well as a cause of lost productivity.  
In general, the ‘udder health’ of the UK national dairy herd (both conventional and organic) has improved dramatically over the 
last 20 years. In 1986, the average Bulk Milk Somatic Cell Count (BMSCC)  was 352 (‘000 cells/ml). By 2000, the average 
had been brought down to 165 (‘000 cells/ml) by a combination of pressure from milk purchasers for improved quality in the 
product they purchased, control measures such as the NIRD - Five Point Plan (Hygienic teat management - combined with 
sound housing management, Prompt treatment of clinical mastitis, Dry cow therapy, Culling chronically affected cows, Correct 
maintenance of the milking machine). The average incidence rate for clinical mastitis (IRCM) in the UK is, between 38 
cases/100 cows/yr (Berry, 1998) and 43 cases per 100 cows/yr (Kossaibati, 1998). SID 5 (2/05)  Page 8 of 29 
Changes in the genetic ‘type’ of cow, and concentration on control of specific mastitis causing organisms including Staph 
aureus, Strep Uberis, Strep dysgalactiae, Strep agalactiae and coagulase negative Staphylococci, and, less commonly 
Corynebacterium bovis have also contributed to this reduction in the National BMSCC. The benefits of reducing the cell count 
of milk are that this may reduce cross infection between cows at milking and hence reduce the incidence of clinical mastitis, 
may improve the quality and food safety of milk, and also maximises the price through bonuses or penalties paid on the basis 
of somatic cell count. There is a well established relationship between the time of year and average BMSCC’s, and older cows 
tend toward higher cell counts (and so herds with a higher proportion of older cows tend toward higher BMSCC’s. There is 
also a difference in the average BMSCC between the morning milking and the evening milking in many herds.  
 
When dairy farms convert to organic production, they are encouraged; 
 
   ‘to sustain animals in good health by the adoption of effective management practices, including high standards for animal 
welfare, appropriate diets and good stockmanship’ (Soil Association Standards) 
 
and to reduce the use of conventional (allopathic) pharmaceutical veterinary treatments, as much as is possible, without 
compromising the welfare of their animals. There is significant pressure from the WHO (World Health Organisation) to reduce 
the use of prophylactic antibiotics in food producing animals, and, in the future it is likely that dairy farmers will increasingly be 
required to justify the use of both milking cow and dry cow antibiotics. 
 
In organically farmed dairy cows, management practices which are promoted (permitted or recommended) in organic 
standards to control mastitis include; 
 
•  Recommended - Frequent stripping, cold water treatments, licensed herbal udder creams 
 
•  Permitted – Homeopathic treatments including nosodes for prevention and Antibiotics – in clinical cases where no 
other remedy would be effective. 
 
On many farms, udder liniments are very commonly used, cold water washing and repeated stripping is sometimes used by 
some farms to treat individual cases of clinical mastitis, and some farms use homoeopathic remedies to treat individual cases 
of mastitis, nosodes to prevent mastitis, and much less commonly, herbal remedies for treating mastitis in individual animals. 
Almost all farms do have to use allopathic treatments (intra-mammary antibiotics, parenteral antibiotics and anti-inflammatory 
agents) on occasion to treat individual sick animals, and this is permitted within the organic standards to ensure that the 
welfare of animals is not threatened if conventional treatments appear to the most appropriate route to a cure.  
 
The range of homeopathic treatments used on farm today is wide, with treatment practices either focussing on the needs of 
the individual animal (which is known as constitutional treatment), using individual remedies tailored to each animals needs. 
Sometimes groups of animals are treated using specific remedies or nosodes.  Sometimes the treatments are given with 
advice from a homeopathic vet or a homeopathic pharmacy, and sometimes the treatments are given after the farmer  has 
researched their use from guides, books or materia medica. Some farmers become very proficient in choosing and using 
remedies, whilst others use the information provided in guides and do not progress to a ‘complex’ understanding of the use of 
these remedies.  
 
There are three commonly used measures of the udder health of milking cows. 
 
a) The bulk milk somatic cell count (BMSCC, commonly referred to as SCC) gives a count (in 000’s cells / ml) of white 
cells and desquamated cells shed by the udder. If the udder is not under challenge by mastitis causing organisms, then a 
low but constant population of cells are shed and the SCC will be low.  Young animals also have a lower mean SCC than 
older animals. However, with inflammation, disease (mastitis), or immediately post calving, the SCC is raised. Milk from 
the bulk tank is sampled routinely by the milk purchaser as part of their quality assessment procedures, and also as a 
basis for quality payments to the farmer. This bulk milk somatic cell count (BMSCC) information is of some value to the 
farmer in monitoring the udder health of his cows. However, because farmers usually remove the milk of individual high 
cell count cows (either by not milking them, or by diverting the milk from these cows to waste, or to feed calves), the 
BMSCC is not an accurate indicator for the presence of clinical mastitis, but may give information on subclinical 
(undetected) mastitis. 
b) Somatic cell counts for individual cows for farms which subscribe to commercial milk recording services (ICSCC).  
c) The number of cases of mastitis. The incidence rate for clinical mastitis (IRCM) is the number of distinct cases of 
mastitis in 100 cows in a year. 
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Farmers use a variety of recording systems for the incidence of disease, including mastitis, and do not have uniform recording 
systems for disease incidence or for the success or failure of their treatments. Some very effective computerised systems do 
exist, such as InterherdTM, which can provide detailed information on a number of herd measures, including mastitis. These 
rely on the farmer subscription to a recording programme such as the National Milk recording scheme which provides 
management information on individual cow’s performance in terms of milk parameters, including individual cow cell counts, 
yield and fertility.  
 
Farmers who are not on recording schemes for individual cell count can use methods such as stripping on to the floor or into a 
strip cup (visual examination of raw milk), the California milk test (CMT) which causes visible agglutination of somatic cells, 
milk conductivity testers, or in line clot filters, to detect mastitic milk.   If they are able to detect them, most farms keep the milk 
of high cell count cows out of the bulk tank to control their BMSCC.  For farms which can identify the cell counts of individual 
cows through milk recording, this information, along with the incidence rate for clinical mastitis for the cow is used as a factor 
when deciding whether to keep the cow in the milking herd, or to cull it. There has also been a certain amount of selection of 
breeds of dairy cows with a reputation for low mastitis incidence, for example Swedish Red or British Holstein.  
 
What is a nosode? 
 
Nosodes are considered to be a very specific form of homeopathy - isopathy   
( iso - all the same,  pathy – treatment/exposure)  
 
Like other homeopathic remedies, a nosode follows the principle of ‘like curing like’. Nosodes are usually used to treat groups 
of animals, and a mastitis nosode uses milk collected from high cell count animals of the herd to be treated, along with a 
general sample from healthy herd members. Some established nosodes can be bought ‘off the shelf’ i.e. they are not created 
from the milk of the cows they will treat, but are made originally from the milk of another herd of cows (such as Ainsworths 
Udder Care & Udder Health). Relative to dry cow or blanket antibiotic therapy, the use of a nosode is usually less expensive, 
however, nosode remedies can cost significant amounts (up to £400 per year for a 100 cow herd). 
 
When the original samples have been collected, a series of dilutions are made – a dilution  of 1 in 100 is known as a 
Centesimal (C).  Between each dilution the mixture is succussed - energetically shaken, and the energetic properties of the 
remedy are believed to be acquired during this process 
An example – a common potentisation = 30 C 
 
This = 30 x 1 in 100 dilutions,  or 1 in  1029 
A  6C, 30C and 200C potentised nosode is commonly made by a homeopathic pharmacy, and this service – manfacture of 
herd specific nosodes made from high cell count milk from the herd to be treated, is available as a commercial process from a 
number of well recognised homeopathic pharmacies, and is also performed by a number of individual homeopathic 
practitioners in the UK. 
 
•  Unlike specific remedies, nosodes do not account for the individual needs of each animal, but create the potential for 
protective treatment for a herd or group  
•  Nosodes are generally applied in drinking water, and may be used on individual animals, usually by vulval spray.  
•  Nosodes are very widely used in organic dairy farms in this country  - in this study, 70% of the farms have used in 
the past, or are at present using, mastitis nosodes. 
 
Farmers store and use nosodes and individual homeopathic remedies in a variety of ways. Many make up a plastic box 
containing the remedies they commonly use, and have this box available in the parlour or in the drugs cabinet. Some 
photographs of real examples of remedy ‘kits’ and guidance, as created by a farmer, are provided in figure 1. 
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Figure 1. Farmers created their own systems for using homeopathic remedies, often making up kits which can be used day to 
day in the parlour or in the yard. 
 
Farmer created guide to the use of 
remedies. 
Remedy box, with a wide range of 
individual remedies. 
Daily use dilutions in spray bottles 
for application to individual cows. 
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Objectives 
 
To quantify the effectiveness of the prophylactic use of  homeopathic nosodes for the treatment of mastitis in reducing the 
incidence of clinical cases. An outline of the recruitment, treatments and analysis of the farms is produced below.   
 
 
MATERIALS AND METHODS  
 
At the inception of the study, a number of homeopathic practitioners were consulted. They suggested that; there should be 
clear presence of a disease to investigate, that the disease should be of significant incidence, that the disease should be 
easily identifiable, and that it should be possible to deliver the medication to the animals effectively. Additionally, they 
considered it important that adequate recording should be possible, that the disease should be amenable to treatment with a 
single or very limited number of remedies and that confounding factors should be recognised. 
 
Recruit farms through the organic 
farming press, Omsco & Soil 
Association (104 farms) 
Visit farms to; 
1) Describe the study and leave material required to collect 
the milk samples for the nosode to be made – samples sent 
by farmer to Glasgow 
2) Collect background farm information and cell count  and 
mastitis cases baseline data 
A number of farms 
withdraw at this stage 
(96 remain) 
Nosode remedy manufactured in 
Glasgow by Freemans homeopathic 
pharmacy  Remedy (R) and non-remedy (P) made up in bulk by 
Crossgates homeopathic pharmacy and sent to Bristol for 
allocation to farms 
Blind random allocation of R or P 
treatment to farms  
Cows receive R or P treatment in water following 
protocol  
A number of farms drop out during this 
period due to sale of herd, or going into 
heifer rearing (88 remain) 
Collection of ongoing cell count, mastitis case and 
management information 
For farms which started the study early,  in year two,  
treamtment is crossed over from R to P ( or P to R) 
for year 2 
Final collection of data required for analysis  Analysis and report writing SID 5 (2/05)  Page 12 of 29 
Mastitis is a common disease problem, which leads to motivation to ‘understand it’, but it is one of the most complex disease, 
with multiple causative agents and aetiologies. This means that studies in the complex area of the interaction between 
mastitis and, for example, homeopathic treatments can be subject to difficulties. In efforts to reduce the confounding effects 
that might occur if prescriptive recording and descriptive techniques are introduced to established animal systems, it was 
determined that the study should;  
 
•  Use a treatment which was already being commonly used and which was commercially available. 
•  Use the existing systems for recording disease which were already in place on the farms. 
•  Avoid interference in the ‘normal’ practises carried out by the farms, by, for example, repeated prompting of farmers 
to carry out treatments, or by interference in the decisions made on whether to treat animals, and on whether or not 
to record  cases of mastitis. 
 
The response variables that were measured were; 
 
•  Farmers own record of mastitis cases 
•  Bulk milk SCC  
•  Individual cow somatic cell records (ICSCC) if the farms were on a milk recording service  
•  Farmers opinion of his/her success in controlling mastitis 
•  A large number of variables, recorded as a questionnaire (Appendix A) at the farm visits, which could influence the 
effectiveness of the treatment  
 
Treatment allocation 
 
After visiting a number of homeopathic pharmacies, an agreement was made with Crossgates homeopathic pharmacy1,  and  
Freemans Homeopathic Pharmacy2  to make the individual herd specific nosode remedies for the farms.  Freemans 
manufactured the ‘mother tincture’ the primary remedy which was created from the milk samples supplied by each farm, and 
Crossgates created the following volume treatments; 
 
•  1l and 500ml containers of 200C nososde – in the winter containing the herd specific remedy alone, and in the 
summer, containing a 30C fly remedy routinely added to their proprietary summer remedy. 
•  10M individual 50ml sprays of the same treatment for application to the vulva or nasal mucosa of individual cows 
showing clots. 
 
 
Agreement was reached with the pharmacies to produce equal quantities of remedy and of a non remedy control  in identical 
containers, with identical batch numbers, distinguishable only by a temporary label which was removed at the ‘blinding’ stage. 
 
 
Figure 2. Examples of the remedy presented as a 1 
litre bottle of 200C with a pump for inclusion in water 
troughs, and  a 10M spray for application to the vulva 
or to the nasal mucosa. 
 
 
 
Blinding was carried out by the creation of a randomly generated list of A and B’s. As each new farm was recruited, it was 
allocated to the next A or B in the sequence and the farms were allocated one by one in chronological order. 
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Recruitment of farms 
 
Articles were written in the organic press, Organic farming and The Turning Worm, inviting farms to take part in the study. It 
was clear that farms should only join the study voluntarily and would not be ‘cold called’ or pressurised to join. One hundred 
and four farms responded to the call, and 96 of these farms went on to take part in the study.  
 
The farms were visited and the study introduced. Farms who wanted to contribute to the study were issued with a kit to collect 
milk from high cell count cows.  The farmers collected 15ml milk samples from 10 to 20% of their herd, selecting any cows 
which they knew to have recently had high cell counts, to be freshly calved, or cows known to be susceptible to repeat cases 
of mastitis. These samples were combined in a clean container, and 10ml of this pooled sample was posted to the 
homeopathic pharmacy. The sample was used to create the mother tincture, the origin of the herd specific nosode remedy. 
The pharmacy created the remedies using their established commercial process. The clear intention of this study was to use 
commercially available homeopathic products without any modification.  
 
An 80 part questionnaire was used to gather the information needed to assess the possible compounding factors that may 
influence mastitis. The questionnaire can be found in appendix A. 
 
In summary, 9670 cows were exposed to the study, and the number of farms, and the number of years combined gives a 
combined study group size of 206 farm years, 21,580 cow years.   
 
Instructions for use of the treatments 
 
When the farmers received their treatments, they were instructed; 
 
       
    3 pumps into every trough -        Daily for the first week 
                            Twice a week in the second week 
                                                                 Once a week thereafter 
 
     Record your mastitis cases and other treatments as you always have 
 
 
A typical pack of bulk treatment (1l or 500ml bottles or 200C treatment, and an individual 50ml spray of 10M treatment)  can 
be seen in Figure 2.  
 
In each year, the balance of farms receiving remedy ( R ) and non remedy ( P ) were as follows (Table 3); 
 
Table 3.  Distribution of remedy ( R  ) and non remedy ( P  ) in the three years of the study. 
 
Year   % farms 
receiving R 
% farms 
receiving P  
% farms changing –  
  R to P or P to R 
0  (control  year)  0 0 0 
1  48%  (42) 49%  (43) 3%    (2) 
2  43 %(9)   52% (11)  5%  (1) 
 
 
A distinct policy of non interference was adopted. The concern was that repeated prompting of farmers to use the remedy, 
and advice giving, would modify the usual behaviour of the farmers. It was the clear intention to allow farmers to choose to 
use the remedy in ways which were natural to their normal working patterns. 
 
RESULTS  
 
The results from this study break down into three areas; 
 
A)  Descriptive statistics – which contain much ‘outline’ information on the organic dairy farms in the study group. 
B)  An analysis of the efficacy of the nosode treatment in reducing the cell count of each farm and cases of mastitis. 
C)  An analysis of the risk factors for increased cell count and cases of mastitis – the wide range of practices, farm 
conditions, operating procedures and attitudes which can influence the management and health and welfare of the 
cows 
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A) DESCRIPTIVE STATISTICS 
 
Group statistics 
 
Number of farms recruited      = 96 
Total farms completing the study period  = 88 
Number of farm years followed    = 206 
Average herd size      = 101 cows 
Number of cows followed in the study   = 9,680 
Number of cows receiving remedy  (R)   = 4,734 
Number of cows receiving control (P)  = 4,946 
Total cow years followed      =  21,580 cow years (Some farms two years, some 3 years) 
Farms lost during study      = 8  (due to sale of the herd, or going out of milk production  
and into, for example, heifer rearing) 
 
Treatment statistics 
 
Winter -  200C Herd specific remedy      = 300 litres used 
Summer - 200C Herd specific remedy + fly remedy     = 325 litres used 
10M individual sprays used         = 236 (11.8 litres used)  
Average cost to treat a farm with the 
     remedies above for each year of the study    = £241.50 
 
 
Basic statistics for the farms taking part in the study 
 
A summary of the statistics resulting from the farm questionnaire can be found in Appendix A. 
 
 
Voluntary personality type for farmers 
 
During visits the farmers were asked whether they were willing to fill in a self assessment of their personality type. For those 
who were willing (the majority were) the ’average’  values for these self filled descriptions are tabulated below. The simple 
representation of the ‘average’ profiles for farmers on farms receiving remedy ( R ) and those not receiving remedy ( P ) are 
tabulated in the tables tables contained in Appendix B. The rationale for requesting this voluntary information was to form the 
basis of an analysis of the following questions; 
 
a) Were there unforeseen differences between the farmer personalities between the control and treated farms? 
 
The ‘average’ personality profile for farmers in both treated and control farms are very similar. The average score for each trait 
was the same except in the following categories ‘conscientious’, ‘shy’, ‘practical’ - which differed by one score (See tables 5 & 
6). 
 
b) Did farmer personality act as a significant factor in udder health? 
 
The personality ‘traits’ were explored by adding them as possible risk factors to the risk factor models described below for 
composite cell count and mastitis cases.  The same criteria as described below were used to fit a model.  
 
•  Of all the traits, self scoring high levels of ‘emotional stability’ (see tables 5, 6, 7 for question structure) was a risk 
factor for both composite cell count (F=4.292, P=0.043) and mastitis cases (F=7.012, P=0.011). Those scoring 
themselves as less emotionally stable were associated with farms with both lower composite cell count and clinical 
mastitis cases.  
•  High levels of ‘self sufficiency’ were linked with increased cell count (F=12.454, P=0.001), but were not associated 
with mastitis cases. 
•  High levels of  ‘shrewdness’ was linked with reduced cell count (F=3.38, P=0.071), but was not associated with 
mastitis cases. 
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B) & C) ANALYSIS OF THE EFFECTS OF THE NOSODE TREATMENT AND ANALYSIS OF RISK FACTORS 
 
Recap of Study Design 
Ninety-six farms participated in a double-blind trial to compare a homeopathic nosode and an inactive control treatment 
(carrier alone). Treatments were at the farm level and took place over a period of 12 months and 24 months. The treatments 
were randomised to each farm by a third party. During the trial, where available, records were collected of farm monthly bulk 
tank somatic cell count (BMSSC), a monthly cell count based on National Milk Recording data (NMR) and the annual number 
of cases of mastitis as recorded by the farmer. Records of these variables for the year preceding the trial were also available 
and these were used in some analyses as covariates to reduce between farm variability and so increase the sensitivity of the 
trial to any effects of treatment. 
 
Ninety six farms took part in the first year of the study, and 14 of the farms were retained in the trial for a further 12 months 
after the treatment on each of these farms had been crossed over to the alternative treatment. This provided a total of 206  
farm years followed, including the lead-in year. 
 
In order to also study risk factors associated with higher cell count farms, and with higher incidence of mastitis, a 
comprehensive survey questionnaire was completed for each farm (Appendix A). 
 
The data collected were subject to a number of different analyses:- 
 
1. A test for an effect of the homeopathic nosode in reducing the cell count in milk. 
2. A test for an effect of the homeopathic nosode in reducing the annual cases of mastitis. 
3. An analysis to identify risk factors associated with increased cell count in milk. 
4. An analysis to identify risk factors associated with higher levels of mastitis. 
 
The approach to each of these analyses is given in detail, below. 
 
 
1. To test for an effect of the homeopathic nosode in reducing cell count in milk 
 
Methods 
 
Table 8 summarises the NMR and SCC data collected. In order to use the available data to the full the SSC and NMR data 
were combined to produce one variable as a measure of monthly cell count for each farm. This was achieved by first taking 
log10 of all counts. The log10 SSC cell counts within each month were then normalised (converted to z - scores) and similarly, 
the monthly NMR cell counts within each month. As NMR measurements are considered to be a more accurate reflection of 
cell count the normalised monthly NMR data were used primarily but where these were not available the normalised SSC data 
were substituted. The new variable was named combined cell count (CCC). 
 
The response variable, monthly CCC, was modelled as repeated measurements within farm using the software package 
MLwiN version 2.00 (Institute of Education, London). The monthly CCC for the preceding year was entered into the model as 
a covariate and a sinusoidal curve with a 12 month period was also fitted as cell counts are known to follow a seasonal 
pattern. The approach taken to modelling the crossed-over treatments was that given by Senn (2002) in which treatment and 
period, alone, are modelled. 
 
Table 8  Breakdown of type of cell count available for each farm.  
 
NMR cell count available    
Yes No 
Yes  42 40  SCC 
available  No  6 0 
 
 
Results 
 
The parameter estimates for the fitted model are shown in the MLwiN output in Figure 3. The residuals from the model at both 
the farm and the monthly CCC level were examined using a Q-Q plot and were satisfactorily normally distributed and 
homogeneous. A similar model was fitted to SCC data alone and NMR data alone. All three models were in general 
agreement. Figure 4 shows the monthly farm CCCs by farm and treatment plotted against time on treatment for years one and 
two of the trial. The values on the graph are seasonally adjusted (Sin and Cos in Figure 3) and adjusted for the cell counts in SID 5 (2/05)  Page 16 of 29 
the year preceding the trial (CovCCC in Figure 3). In Figure 4 the nosode treatment is shown in blue and the control treatment 
in red. 
 
Figure 3 The output from MLwiN (Rasbash 2000) detailing the model used to analyse the affect of the nosode on farm 
monthly averaged cell count. 
  
 
Figure 4 Monthly farm marginal mean CCCs plotted against ‘time on treatment’ for year one and year two. The CCCs are 
seasonally and covariate adjusted at the level of month. Farms on the nosode treatments are shown as blue and those on 
control treatments as red. 
 
 
 
 
The significance of the parameter estimates are shown in Table 9. The constant in the model was not significantly different 
from zero. This would be expected as the data had been centred. CovCCC, the covariate of monthly cell counts from the year 
preceding the trial was highly significant indicating that cell counts over time within each farm were strongly correlated. It’s 
inclusion in the model thus helped reduce between farm variation and increased the sensitivity of the analysis to any effect of 
nosode. The fitted seasonal effect was also significant (Sin and Cos) indicating that the seasonal changes in cell count could 
be approximated by a sinusoidal curve. The fitted curve is shown in Figure 5 and shows that the overall minimum cell count 
would be expected in approximately February and the overall maximum in approximately August. There was no significant 
effect of nosode on cell count and no significant difference in overall cell count between the first and second years of the trial. 
The variance components from the model (Fig 3) indicate that 56 per cent of the variability in cell counts was at the farm level 
(0.487/0.865) and 44 per cent at the level of the monthly measurements (0.378/0.865). 
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Table 9 The parameter estimates from the model of the effect of nosode on cell count, with their standard error and 
significance. (Const = Model constant, CovCCC = combined average NMR/bulk cell count in the pre-trial year (transformed), 
Sin and Cos = parameters to model the seasonal changes in cell count, Nosode = effect of the nosode treatment, Year 2 = 
the overall difference in average cell count between years). 
 
  Parameter est.  SE  P   
Const  0.026 0.088 0.768  NS 
CovCCC  0.163 0.032  3.52E-07 *** 
Sin  -0.089 0.028 0.001  *** 
Cos  -0.055 0.028 0.049  * 
Nosode  0.012 0.069 0.862  NS 
Year 2  -0.035 0.074 0.636  NS 
 
 
 
Figure 5 The fitted seasonal trend line is shown in red. The minimum occurs in February and the maximum in August. 
 
 
 
 
The model was used to assess the sensitivity of the study to detect a difference between the control and nosode treatment. 
Using the standard error of the nosode parameter estimate and evaluating the model at the farm average NMR cell count of 
226.2 (which gives a log10 value of 2.255 with standard error 0.2275) gives an estimate for the control treatment of 
approximately 227 counts. The estimate of the cell count for the nosode treatment was then approximately 228 counts with a 
95% confidence interval of 213 counts to 245 counts. Note that the confidence interval is not symmetric due to the log 
transformation and that cell counts are reported in thousands. 
 
 
 
2. To test for an effect of the homeopathic nosode in reducing the annual cases of mastitis. 
 
Method 
 
An annual count of the number of cases of mastitis on each farm was collected. The number of farms for which usable data 
were available was 84 from the first year of the trial and 13 from the second year, in which treatments were crossed over. The 
number of cases as a proportion of the herd size was used for the analysis. The data were first transformed by taking the 
arcsine of the square root of the proportion in order to remove heterogeneity in the variance and the variable was named 
TProp. A count of mastitis cases for the year preceding the trial was also available for these farms and this was used as a 
covariate (CovTProp). A multilevel model was fitted with the repeated measure within farm using MLwiN v2.00 (Institute of SID 5 (2/05)  Page 18 of 29 
Education, London). The approach taken to modelling the crossed-over treatments was that given by Senn (2002) in which 
treatment and period, alone, are modelled.  
 
 
Results 
 
The parameter estimates for the fitted model are shown as the MLwiN output in Figure 6. The residuals from the model were 
examined using a Q-Q plot and were satisfactorily normally distributed and homogeneous. 
 
 
Figure  6 The output from MLwiN detailing the model used to analyse the affect of nosode on the proportion of cases of 
mastitis in a herd (Rasbash 2000). 
 
 
 
The significance of the parameter estimates are shown in Table 10. The number of cases in the year preceding the trial as a 
proportion of the herd (CovTProp) was significant as a covariate. This indicates that the proportion of cases within a farm was 
correlated across years. The inclusion of this covariate will have increased the sensitivity of the analysis to any effect of 
nosode. There was no effect of herd size on the proportion of cases and no effect of nosode on the proportion of cases. There 
was a significant increase in the proportion of cases in year two. The overall proportion of cases in the year preceding the trial 
was 0.27 (0.015) and the overall proportion in the first year of the trial 0.25 (0.014). For the farms which were crossed, alone, 
the proportion of cases in the first year of the trial over was 0.26 (0.042) and in the second year 0.33 (0.051). Of these farms, 
10 showed an increase in cases, two a decrease and one no change. 
 
 
Table  10  The parameter estimates from the model of the effect of nosode on cases of mastitis, with their standard error and 
significance (Const = Model constant, CovTProp = proportion of cases in the herd in the pre-trial year (transformed), Herdsize 
= average number of cows in herd, Nosode = effect of the nosode treatment, Year 2 = the overall difference in cases between 
years).  
 
 
  Parameter est.  SE  P   
Const  0.1574 0.0507  0.002  ** 
CovTProp  0.6235 0.0793  3.76E-15  *** 
Herdsize  0.0002 0.0002  0.317  NS 
Nosode  0.02 0.0235  0.395  NS 
Year 2  0.0778 0.0331  0.019  * 
 
 
 
 
The model was used to assess the sensitivity of the study to detect a difference between the control and nosode treatment in 
terms of cow cases. Using the standard error of the nosode parameter estimate and evaluating the model at the farm average 
pre-trial year (CovTProp) of 28.6 cases per 100 cows per year (incident rate of clinical mastitis (IRCM)) and the average herd 
size of 108.5 cows, the estimated IRCM of the herd as cases under the control treatment was 28.9. The estimated IRCM 
under the nosode treatment was 30.8 with a 95 per cent confidence interval from 28.6 to 33.0. 
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3. Analysis to identify risk factors associated with increased cell count in milk. 
 
Methods 
 
As all the risk factors were farm level factors, a single response measure for each farm was calculated.  Because in the 
previous analysis no effects of period or treatment were identified, where available, data across all three years were used to 
construct a single measure of cell count for a farm. In a similar manner to analysis 1, the monthly SCC counts and NMR 
counts were normalised before being combined into a single index in which the NMR measurements took precedence over 
the SCC measurements. The normalised value, averaged across the months, was then used as the measure of cell count for 
a farm. On this occasion it was not necessary to transform the raw counts to normalise the residuals from the model (a log10 
transformation was not required). 
 
The initial screening and construction of the GLMs was carried out using the software package SPSS v12.02 (SPSS Inc.). All 
of the farm level variables were screened for a linear or additive association with farm averaged cell count (FACC). Variables 
which showed a significant association with FACC, where P ≤ 0.10, were retained for further analysis using general linear 
models (GLM). Models were fitted using both a stepwise forward method and backward elimination. Variables were retained 
in the model if they remained significant or if their removal affected the parameter estimates of other variables in the model. 
Variables that had been dropped from the model were reintroduced into the final model, one at a time, and retained if they 
became significant. 
 
Results 
 
The variables retained in the final model are shown in the analysis of variance table with the parameter estimates below 
(Tables 11 and 12). The errors from the model were satisfactorily normally distributed and homogeneous. R Squared for this 
model was 0.21 with an adjusted R Squared of 0.16. The low R squared value of 0.16 shows that only 16 per cent of the 
variation in farm average cell counts is explained by the model. Two variables with 0.05 < P < 0.10 have been retained in the 
model as their presence affects the significance of other variables in the model. The parameter estimates indicate that farms 
with a high percentage of cows culled because of high cell counts were associated with lower annual average cell count as 
were farms that used either traditional dry cow therapy or a complementary dry cow therapy. Higher annual average farm cell 
counts were associated with farms that only pre-wiped cows which were dirty, did not pre-wipe at all or used a cloth to pre-
wipe udders. 
 
 
Tables 11 and 12  The analysis of variance table and parameter estimates, their standard error and upper and lower 
confidence interval for the final model of risk factors for cell counts. 
 
Source df  F  P 
Corrected Model  5 3.71  0.005 
Intercept  1 8.75  0.004 
Cows culled high %  1 3.23  0.077 
No pre-wipe or use cloth  1 3.88  0.053 
Only pre-wipe dirty  1 4.03  0.049 
Complementary DCT  1 2.87  0.095 
Dry Cow Therapy  1 4.10  0.047 
 
 
Parameter B  SE  t  P  LCI  UCI 
Intercept  0.006 0.1508  0.04 0.969 -0.295  0.307 
Cows culled high %  -0.054 0.0301 -1.80 0.077 -0.114  0.006 
No pre-wipe or use cloth  0.376 0.1911  1.97 0.053 -0.005  0.758 
Only pre-wipe dirty  0.314  0.1562 2.01  0.049 0.002 0.625 
Complementary DCT  -0.310 0.1830 -1.69 0.095 -0.675  0.055 
Dry Cow Therapy  -0.326 0.1609 -2.03 0.047 -0.647 -0.005 
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4. Analysis to identify risk factors associated with higher annual numbers of mastitis cases 
 
Methods 
 
Both the risk factors and the response variable were measured at the level of farm. The response variable used in the 
analysis was the proportion of cases in the herd averaged over the year preceding the trial and the first year of the trial. These 
proportions were transformed by taking the arcsine of the square root in order to remove heterogeneity in the variance and the 
variable named TAvProp. Data for the second year of the trial were not included as the subset of farms that were carried into 
the second year of the trial had shown an increase in cases. 
 
The initial screening and construction of the GLMs was carried out using the software package SPSS v12.02 (SPSS Inc.). All 
of the farm level variables were screened for a linear or additive association with TAvProp. Variables which showed a 
significant association, where P ≤ 0.10, were retained for further analysis using general linear models (GLM). Models were 
fitted using both a stepwise forward method and backward elimination. Variables were retained in the model if they remained 
significant or if their removal affected the parameter estimates of other variables in the model. Variables that had been 
dropped from the model were reintroduced into the final model, one at a time, and retained if they became significant. 
 
Results 
 
The variables retained in the final model are shown in the analysis of variance table with the parameter estimates below 
(Tables 13 and 14). A Q-Q plot of the errors from the model showed them to be satisfactorily normally distributed and 
homogeneous. R Squared for this model was 0.38 with an adjusted R Squared of 0.34. The parameter estimates indicate that 
higher farm average yield was a risk factor for mastitis, as was increased percentage of cows calving in a box. Using an in-line 
clot filter and having an abreast parlour, rather than a herring-bone parlour, were both associated with a lower proportion of 
mastitis cases on a farm. 
 
 
Tables 13 and 14  The analysis of variance table and parameter estimates, their standard error and upper and lower 
confidence interval for the final model of risk factors for cases of mastitis as a proportion of herd. 
 
Source df  F  P 
Corrected Model  4 8.73  0.000 
Intercept  1 8.05  0.006 
Average Yield  1 4.49  0.038 
Inline Filter  1 5.16  0.027 
Calve in Box %  1 9.36  0.003 
Abreast Parlour  1 4.23  0.044 
 
 
 
Parameter B  Std.  Error  t  Sig.  LCI  UCI 
Intercept  0.3003 0.09321 3.22  0.002  0.1137  0.4869 
Average Yield  1.33E-5 0.00001 2.12  0.038  0.0000 0.0001 
Inline Filter  -0.0772 0.03399 -2.27  0.027  -0.1453  -0.0092 
Calve in Box %  0.0019 0.00063 3.06  0.003  0.0007  0.0032 
Abreast Parlour  -0.0881 0.04287 -2.06  0.044  -0.1740  -0.0023 
 
 
 
 
DISCUSSION 
 
Questionnaire  
 
The results of the questions asked during the farm visits provide basic statistics for the farms studied. The ‘average’ farm in 
the study (of course there is no average farm) has been converted to organic production for nearly six years, has 109 cows, 
produces 5900 litres of milk per cow/year (national average 6,609 litres/yr (Milk Development Council datum 2004)), has Black 
and White Friesian/ Holstein cows and milks the cows in a herring bone parlour. The farm replaces just over 20% of its 
animals each year, calves its young cows first at 27 months of age, takes the calf away from the dam at 2 days of age and 
has cubicles to house the cows. During milking, more than 60% of milkers wear gloves, and the majority of cows are made to SID 5 (2/05)  Page 21 of 29 
stand in a loafing area for a period after milking before returning to their accommodation. The farmer estimate for the number 
of cases of mastitis was 23.7 cases/100 cows/yr (the figure calculated from records was 25.8 cases/100 cows/yr, and that 
taken from recording data was 28.6 cases/100 cows/yr), 84% of farms had removed cows from the herd as a result of mastitis 
or high cell counts in the last year, and the average farm had a cow die from mastitis about every 5 years.  Half of the farmers 
had some kind of training in complementary therapy use, and 85% said that they had some belief in complementary therapies, 
with 62% using them on themselves and their families. 
 
These results show the ‘average’ organic farm in the study group to be a productive unit with milk production figures just 
below the national average and an incidence rate for clinical mastitis (IRCM ) of 28.6 cases/100 cows/yr which is below the 
average for conventional farms which was recorded as between 38 cases/100 cows/yr (Berry, 1998) and 43 cases per 100 
cows/yr (Kossaibati, 1998) in two large scale studies in the late 1990’s. 
 
Nosode Trial 
 
No significant effect of the nosode remedy on either somatic cell counts, nor the number of mastitis cases recorded by the 
farmer was found in this study. The data from the trial suggest that, if it had existed, the study would have been able to detect 
a difference due to nosode of at least approximately 15  cell counts (000s) and a difference due to nosode of at least 
approximately 2  cow cases/100 cows/yr. Within the study group, there was good correlation between bulk tank counts 
(BMSCC) and averaged cow counts from national milk recording (NMR). However, NMR averages are higher than BMSCCs 
because high cell count milk is excluded from the bulk tank but high cell count cows are still NMR recorded. For this reason 
the two available measures of cell count were combined as described above so that the model describes deviations which are 
standardised across types of count. The seasonal trend in cell count identified in the study, with a minimum occurring in 
approximately February and a maximum in approximately August, is well documented in the literature. 
 
Many of the farmers had previously used nosode therapies for mastitis in the past, and a number were firmly of the opinion 
that, for them, homeopathic remedies, including nosodes, were of value and had a place in their management of mastitis (and 
other dairy cow conditions). For these farmers, the results of this study will be a disappointment, whilst for others these results 
will not be seen as unexpected. The experience of the authors during this study was that many organic dairy farmers had a 
very intelligent and practical approach to mastitis management, using complementary therapies where they saw them to be 
appropriate, but not withholding the use of stripping, udder liniments, removal of high cell count animals from the herd, and 
targeted use of antibiotics when the health and welfare of their animals demanded their use. During the trial a number of 
farmers were convinced that, for them, the treatment they received was beneficial. This applied both to farmers on nosode 
treatments and on control treatments. Appendix B contains an example of a letter (anonymised) from one of these farmers.  
 
 
Risk Factors 
 
For each factor, a question appears in the questionnaire (Appendix A) and the response of the farmers, or the visible finding 
on the farm, was used to assess the impact on cell count and the number of clinical mastitis cases. Below, the ‘question’ that 
was asked for each risk factor which was found to have a significant association with mastitis is used as a heading for a brief 
commentary on the possible implications of that risk factor. 
 
 
Risk factors for high cell counts 
 
a) What percentage of the herd was culled due to a high cell count? 
 
For farms which cull significant numbers of cows with high cell counts, there was a significant decrease in cell count. This 
finding is in agreement with the principles of the five point plan (Cull chronically infected cows) and is considered a 
fundamental tool in controlling cell count. However, in organic systems, culling of cows, unless essential, is sometimes 
considered to go against the wider principles of holistic production – i.e. to make every effort to sustain animals in production 
for a reasonable proportion of their normal lifespan – and culling of cows at 4, 5, 6 or 7 lactations when a cows can sustain 
milk production until 12 lactations, is seen by many organic farmers as a failing. 
 
b) Did the farmer pre wipe the teats with a cloth, medicated wipe or paper towel before milking?   
 
For farmers who did not wipe the udder before milking, and for those who used a reusable udder cloth, (usually with warm 
disinfectant containing water), there was a significant positive correlation with composite cell count. This supports the often SID 5 (2/05)  Page 22 of 29 
stated view that a common udder cloth (or no pre wiping) can adversely affect cell count. Many dairy standards prohibit the 
use of a common udder cloth. 
 
c) Did  the farmer pre wipe only cows which are visibly dirty before milking? 
 
For farmers who wipe only the udders of cows which are visibly dirty before milking, a positive correlation with composite cell 
count exists – i.e. those farmers who only wipe dirty udders appear to have a higher overall composite cell count. 
 
d) Did  the farmer use complementary therapies on dry cows? 
 
Some of the farms (17 of 88, 19%)  used complementary therapies such as nosodes for ringworm prevention, for dry cow 
mastitis, for new forest eye and for coughing or lameness, on groups and individual dry cows. For those farms indicating that 
they did use these therapies on their dry cows, the negative correlation seen supports the supposition that use of 
complementary therapies during the dry period is associated with decreased composite cell count. The question used to 
explore this area is a very generalised one, and does not restrict itself to mastitis treatments alone, and so the significant 
finding in this factor is perhaps difficult to interpret – other than to indicate that the farmers who showed attention to their dry 
cows, by (in these cases) use of complementary therapies during this period showed a decreased composite cell count.  
 
e) Was dry cow therapy used? 
 
Conventional (allopathic) dry cow therapy was used on some farms, at times, to treat both groups of cows and individual cows 
with a history of high cell counts. Additionally, around 25% (this varied from season to season, and with the introduction of 
Orbeseal (Pfizer Animal Health) of the farms used non antibiotic teat sealants during the dry cow period.  The negative 
correlation found supports the supposition that the use of dry cow therapy reduces the composite cell count. 
 
 
Risk factors for higher numbers of cases of mastitis 
 
 
a) What was the annual average yield of the herd? 
 
There was a positive correlation between average herd yield and the number of clinical cases of mastitis.  This means that 
high yielding herds had, in general, an increased proportion of mastitis cases. In this study, this finding appeared to be 
independent of herd size. 
 
b) Was an in-line filter used to detect clots in the milk? 
 
A number of methods for detecting clots and mastitic milk were used by farmers. These included stripping milk onto the floor 
(or onto a Wellington), into a strip cup, onto the plastic tray of a California milk test where a reagent showed high cell count 
milk, or into a conductivity meter, which showed changes in milk electrical resistance with changes in milk composition 
(including cell count).  
Many milking systems had visible filters in the milk tube, which the farmer could inspect to detect gross clots. The farmers 
chose to include, or exclude, milk from the bulk tank in systems which were not ‘direct to line’, and also chose to treat animals 
showing clots or early signs of mastitis using these tests. The Dairy Products (Hygiene) Regulations 1995 require examination 
of foremilk before the cluster is put on and milk allowed into the bulk tank. How farmers carry out this examination is linked 
with their methods for detecting mastitis through examination of milk character and for clots, and by familiarity with individual 
cow behaviour (reactions to a tender udder, sick cow, position in the milking queue etc.). 
 
Of all the methods described, only the use of the in line filter showed a negative correlation with the number of clinical mastitis 
cases recorded by the farmer i.e. use of an in line filter appears to have a significant effect in reducing the number of mastitis 
cases. 
 
c) What percentage of the herd calved in a box? 
 
Farms operated many different calving patterns and systems. Some calved almost exclusively on grass, some calved indoors 
in yards, and some in dedicated calving pens or boxes – most farms actually used a mixture of these, calving in locations 
determined by the season and the availability of space.  Whether contamination of the udder could occur more readily in a 
calving box during calving, or whether the use of calving boxes reflected other management practices cannot be determined SID 5 (2/05)  Page 23 of 29 
in this study, however, farms where the cows predominately calved in dedicated calving boxes appeared to be linked with 
significant increases in composite cell count. 
 
d) Did the farm have an abreast parlour or a herring-bone parlour? 
 
Three main  types of milking parlour are found in the UK, herring bone (80%), abreast (17%) and rotary parlour (3%). (In 
brackets are the percentage of each parlour type found in the farms in this study.) For the two more common types, farms with 
an abreast parlour, a significant reduction in composite cell count was seen. Whilst many people associated herring bone 
parlours with updated farms and abreast parlour with traditional milking, in this study, traditional abreast parlours appeared to 
beneficially affect composite cell count performance. 
 
Comparison between the risk factors found in this study and the ‘Five Point Plan’ 
 
The existing NIRD Five Point Plan is widely adopted by the UK dairy industry and recommends; Hygienic teat management - 
combined with sound housing management, Prompt treatment of clinical mastitis, Dry cow therapy, Culling chronically 
affected cows and Correct maintenance of the milking machine. Because the majority of risk factors that have been identified 
in the present study are in line with the ‘Five Point Plan’ it may not be considered appropriate to issue specific additional 
guidance for organic dairy farms. 
 
 
Conclusions 
 
The study has identified; 
 
•  That there was no significant effect of the herd specific nosode on either the cell counts or the number of cases of 
mastitis was identified. 
•  That there were strong ‘within farm’ correlations of cell count and cases i.e. farms tend to stay at the same level of 
cases and average cell count from year to year. 
•  That there was a characteristic pattern of seasonal change in cell counts (this is already widely recognised). 
•  The study provides useful and interesting statistics on organic dairy farm production. 
•  The study identified an association between decreased cell count and culling for high cell count, complementary dry 
cow therapy and traditional dry cow therapy. 
•  The study identified an association between increased cell count and not pre-wiping the udder, pre-wiping using a 
cloth and only pre-wiping dirty cows. 
•  The study identified an association between higher numbers of mastitis cases and higher average yield and also with 
a higher percentage of cows calving in a calving box. 
•  The study identified an association between decreased numbers of mastitis cases and the use of an inline clot filter 
and also with farms with an abreast parlour (rather than a herring-bone parlour). 
•  Eighty five per cent of farmers in the survey responded that they did believe in non-conventional remedies, and 62 
per cent of farmers responded that they used non-conventional remedies on their own family. 
•  In a ‘self scoring’ exercise for the type of personality of the farmers in the study,  high levels of ‘emotional stability’ 
(see tables 5, 6, 7 for question structure) were a risk factor for both composite cell count (F=4.292, P=0.043) and 
mastitis cases (F=7.012, P=0.011). Those scoring themselves as less emotionally stable were associated with farms 
with both lower composite cell count and clinical mastitis cases.  
•  High levels of ‘self sufficiency’ were linked with increased cell count (F=12.454, P=0.001), but were not associated 
with reduced or increased numbers of mastitis cases. 
•  High levels of  ‘shrewdness’ were linked with reduced cell count (F=3.38, P=0.071), but was not associated with 
either reduced or increased numbers of mastitis cases. 
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Appendix A 
 
Table A  Summary table of responses to question or factors which can be broken down to single answers. For factors with a 
number of answers, the correlation table (Table 5) gives values for significance. 
 
Relates to 
questionnaire 
question 
number 
Factor Answer  options  Mean 
  
Min Max  SD 
A1b Average  time converted ?         5.7 yr  2 yr  50 yr  6.24 yr 
A2  Which certification body are you 
converted with ? 
 
 
76% 
 
 
24% 
    
B1    What stock do you have on the 
farm at the present time ? 
Dairy cows 
 
Beef cows 
109.76 
 
28.70 
9 
 
0 
550 
 
320 
76.39 
 
64.18 
B3  What was the herd average milk 
yield per cow per year last year? 
Litres/yr  5976  2500 9500  1306.36 
B4   Age of oldest milking cow ?  Years  9.52  6 14  2.35 
B5  What breed are the majority of 
your dairy cows at the present 
time? 
Friesian/Holstein 
Ayrshire 
Channel Island 
Brown Swiss            
Norwegian / 
Swedish Red 
89% 
2.5% 
8% 
<1% 
<1% 
<1% 
    
B6  Have you changed breed  (or, 
are you in the process of 
changing breed) in the last 12 
months. 
Yes (%)   32%  0 1  0.467 
B7  How many replacement cows 
and / or heifers did you 
introduce during the last 12 
months? 
  21%  0% 50%  9.7 
B8  Average age at which heifers 
are calved? (Months) 
 
 
26.9   23 33  2.51 
C6  What type of housing do you 
now have for milking cows? 
Cubicles 
Straw yard  
74% 
26% 
    
C7  Do you have an automatic 
scraper system? 
Yes (%)  19%  0 1  0.392 
C10  Is lime added to the bedding   Yes (%)  46%  0 1  0.499 
D6  Did you teat dip during the dry 
cow period in the last 12 
months? 
no cows  
 
26%  0 1  0.44 
D7  Did you use complementary 
therapies for groups of dry cows 
during the last 12 months ? 
Yes (%)  
 
20%  0 1  0.40 
E2  If you calved cows / heifers in 
individual pens / boxes: 
 
how many pens / boxes 
did you have? 
 
what proportion of cows 
/ heifers calved in 
them? 
 
   
 
 
2.7 
 
 
 
57.7% 
 
 
 
1 
 
 
 
5 
 
 
 
9 
 
 
 
100 
 
 
 
2.05 
 
 
 
25.24 
E4  How soon after birth were 
calves removed from their 
mothers? (Days) 
  2.4  1 4  1.13 
G2  Was the plan compiled with 
veterinary input ?   
Yes (%) 
 
58%  0 1  0.49 
G3  Is the plan updated  ? 
If so, how often? 
  71%  0 1  0.45 
H1  In the last year have you culled 
any cows because of mastitis? 
Yes (%) 
 
84% 
 
0 1   
H2  Did any cows die from mastitis 
in the last 12 month period? 
How many ? 
(Average number 
of cows dying per 
year from 
mastitis) 
0.23  0 2  0.443 
Formatted: Bullets and
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H3  What is the farmer estimate for 
the percentage of cows affected 
? 
% Estimate for 
mastitis incidence 
23.7 
(cases/100 
cow/yr) 
3 60  13.79 
H4  From the disease and medicine 
records kept for certification 
purposes, and with the farmer 
adding additional information 
from other records, medicine 
records and from memory, the 
identifiable individual cases for 
mastitis in the last 12 months. 
  25.83 
(cases/100 
cows/yr) 
0 70  15.03 
I3  Does it have an automatic 
cluster removal (ACR)? 
Yes (%) 
 
48%  0 1  .5 
I6  How often do you currently 
change the liners?  
(Months)  7.17  3 12  2.66 
I11  What type of milking parlour do 
you have ? 
Abreast 
Herring bone 
Rotary 
17% 
80% 
3% 
    
J1  During the last 12 months how 
many people regularly milked 
the cows (i.e. not reliefs)? 
  1.8  1 5  0.86 
J7a  Did the people doing the milking 
wear gloves? 
 
Are disposable gloves used? 
Yes (%) 
 
 
Yes (%)   
63% 
 
 
60% 
0 
 
 
0 
1 
 
 
1 
0.52 
 
 
0.49 
J7b  Did you keep the cows in a 
loafing area (standing only) after 
milking, in the last 12 months? 
Yes (%) 
 
 
66%  0 1  0.47 
K3  In the last 12 months did you 
wash the teats of any cows 
before milking?  
 
Did you dry the teats after 
washing? What did you use? 
Yes (%) 
 
 
 
Paper towel 
  
25% 
 
 
 
60% 
 
0 
 
 
0 
1 
 
 
1 
0.43 
 
 
0.49 
L2  Do you clean the water troughs 
? 
Yes (%) 
 
49%  0 1  .50 
M4  Has the stockperson had any 
training in complementary 
medicine use ?              
Yes (%) 
 
50%  0 1  .50 
M5  Does this person feel that 
training in homeopathy would be 
of value ?                   
Yes (%)  83%  0 1  .44 
M6  Does this person ‘believe’ in 
non-conventional remedies ?         
Yes (%)  85%  0 1  .49 
M7  Does this person use 
complementary therapies on 
themselves or their family ?   
Yes (%)  62%  0 1  .49 
 
 
Appendix B 
 
Table B1  ‘Average’ values for the personality questions voluntarily self filled by farmers in the group receiving remedy ( R ). 
 
 -3  -2  -1  0  1  2  3   
Reserved         3     Outgoing 
Less  emotionally  stable       3   Emotionally  stable 
Confident     3       Lacking  confidence 
Humble       3      Assertive 
Serious       3        Happy go lucky 
Expedient         3     Conscientious 
Shy       3      Venturesome 
Tough minded        3      Tender  minded 
Trusting     3       Suspicious 
Practical       3      Imaginative 
Unpretentious       3      Shrewd 
Traditional         3     Experimenting 
Group  dependent       3   Self  sufficient 
Independent     3       Concerned  with  image SID 5 (2/05)  Page 26 of 29 
Relaxed     3       Tense 
Less intelligent          3     Intelligent 
 
Table B2 ‘Average’ values for the personality questions voluntarily self filled by farmers in the group not receiving remedy ( P ). 
 
 -3  -2  -1  0  1  2  3   
Reserved         3     Outgoing 
Less  emotionally  stable       3   Emotionally  stable 
Confident     3       Lacking  confidence 
Humble       3      Assertive 
Serious       3        Happy go lucky 
Expedient       3   Conscientious 
Shy         3     Venturesome 
Tough minded        3      Tender  minded 
Trusting     3       Suspicious 
Practical     3       Imaginative 
Unpretentious       3      Shrewd 
Traditional         3     Experimenting 
Group  dependent       3   Self  sufficient 
Independent     3       Concerned  with  image 
Relaxed     3       Tense 
Less intelligent          3     Intelligent 
 
Table B3 ‘Average’ values for the personality questions voluntarily self filled by farmers for all the farms in the study.  
 
 -3  -2  -1  0  1  2  3   
Reserved         3     Outgoing 
Less  emotionally  stable       3   Emotionally  stable 
Confident     3       Lacking  confidence 
Humble       3      Assertive 
Serious       3        Happy go lucky 
Expedient         3     Conscientious 
Shy         3     Venturesome 
Tough minded        3      Tender  minded 
Trusting     3       Suspicious 
Practical     3       Imaginative 
Unpretentious       3      Shrewd 
Traditional         3     Experimenting 
Group  dependent       3   Self  sufficient 
Independent     3       Concerned  with  image 
Relaxed     3       Tense 
Less intelligent          3     Intelligent 
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Appendix D 
 
1Freemans Homeopathic Pharmacy 
18-20 Main Street, Busby 
Glasgow, G76 8DU 
Scotland 
 
2Crossgates Farm Homeopathic Products 
Barrel Sykes, Langcliffe Road, 
Settle, North Yorkshire, BD24 9JT 
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